Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer clinical trials--a chronic but curable crisis.

Literature DB >> 20554976

Cancer clinical trials--a chronic but curable crisis.

Robert C Young¹.

Abstract

Mesh：

Year: 2010 PMID： 20554976 DOI： 10.1056/NEJMp1005843

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. Combating antimicrobial resistance: policy recommendations to save lives.

Authors: Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal: Clin Infect Dis Date: 2011-05 Impact factor: 9.079

2. Recognizing the Financial Burden of Cancer Patients in Clinical Trials.

Authors: Ryan D Nipp; Elizabeth Powell; Bruce Chabner; Beverly Moy
Journal: Oncologist Date: 2015-05-18

3. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.

Authors: Carol P Somkin; Lynn Ackerson; Gail Husson; Vicky Gomez; Tatjana Kolevska; Desiree Goldstein; Louis Fehrenbacher
Journal: J Oncol Pract Date: 2013-10-22 Impact factor: 3.840

4. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Authors: Lynne Penberthy; Richard Brown; Maureen Wilson-Genderson; Bassam Dahman; Gordon Ginder; Laura A Siminoff
Journal: Clin Trials Date: 2012-10-02 Impact factor: 2.486

Cancer clinical trials--a chronic but curable crisis.

1. Combating antimicrobial resistance: policy recommendations to save lives.

2. Recognizing the Financial Burden of Cancer Patients in Clinical Trials.

3. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.

4. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Review 5. Advancing precision medicine for prostate cancer through genomics.

6. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Review 7. Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin.

8. Effort required in eligibility screening for clinical trials.

9. Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.

10. Enrollment of patients with lung and colorectal cancers onto clinical trials.